507462-51-3

Basic information

• Product Name: 5-Bromo-1H-pyrrolo[2,3-b]pyridin-3-amine
• Synonyms: 5-Bromo-1H-pyrrolo[2,3-b]pyridin-3-amine;5-BroMo-1H-pyrrolo[3,4-b]pyridin-3-aMine;1H-Pyrrolo[2,3-b]pyridin-3-aMine, 5-broMo-;3-Amino-5-bromo-1H-pyrrolo[2,3-b]pyridine;5-Bromo-1H-pyrrolo[2,3-b]pyridin-3-ylamine
• CAS NO: 507462-51-3
• Molecular Formula: C₇H₆BrN₃
• Molecular Weight: 212.049
• EINECS: 200-258-5
• Mol File: 507462-51-3.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• Density: 1.867
• Refractive Index: 1.8
• CAS DataBase Reference: 5-Bromo-1H-pyrrolo[2,3-b]pyridin-3-amine(CAS DataBase Reference)
• NIST Chemistry Reference: 5-Bromo-1H-pyrrolo[2,3-b]pyridin-3-amine(507462-51-3)
• EPA Substance Registry System: 5-Bromo-1H-pyrrolo[2,3-b]pyridin-3-amine(507462-51-3)

Safety Data

• Hazardous Substances Data: 507462-51-3(Hazardous Substances Data)

Usage

General Description

5-Bromo-1H-pyrrolo[2,3-b]pyridin-3-amine is a chemical compound with the molecular formula C8H6BrN3. It is a heterocyclic amine with a pyrrolopyridine structure, containing a bromine atom at the 5-position. 5-Bromo-1H-pyrrolo[2,3-b]pyridin-3-amine has potential applications in medicinal and pharmaceutical chemistry, due to its ability to serve as a building block for the synthesis of various bioactive molecules. It may also have uses in the field of organic synthesis, particularly in the development of novel materials and chemical compounds. Additionally, the bromo substituent on the pyrrolo[2,3-b]pyridine scaffold can potentially enable further derivatization and modification of the molecule to tailor its properties for specific applications. Nonetheless, the precise uses and properties of this compound will likely depend on further research and development.

InChI:InChI=1/C7H6BrN3/c8-4-1-5-6(9)3-11-7(5)10-2-4/h1-3H,9H2,(H,10,11)

Upstream product

• 507462-26-2 5-bromo-3-nitro-1H-pyrrolo[2,3-b]pyridine 
• 183208-35-7 5-bromo-1H-pyrrolo[2,3-b]pyridine 

Downstream Products

• 1449318-35-7 1-benzyl-1H-pyrazol-4-carboxylic acid (5-bromo-1H-pyrrolo[2,3-b]pyridin-3-yl)amide 
• 1449319-61-2 1-benzyl-1H-pyrazol-4-carboxylic acid [5-(4-formylphenyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]amide 
• 1449319-59-8 1-benzyl-1H-pyrazol-4-carboxylic acid [5-(4-piperidin-1-ylmethylphenyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]amide 
• 1449319-63-4 1-benzyl-1H-pyrazol-4-carboxylic acid [5-(4-{[(2-methoxyethyl)methylamino]methyl}phenyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]amide 
• 1449319-69-0 1-benzyl-1H-pyrazol-4-carboxylic acid {5-[4-(4-fluoropiperidin-1-ylmethyl)phenyl]-1H-pyrrolo[2,3-b]pyridin-3-yl}amide 
• 1449319-84-9 1-benzyl-1H-pyrazol-4-carboxylic acid [5-bromo-1-(toluene-4-sulfonyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]amide 
• 1449319-87-2 1-benzyl-1H-pyrazol-4-carboxylic acid [5-(3-formylphenyl)-1-(toluene-4-sulfonyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]amide 
• 1449319-89-4 1-benzyl-1H-pyrazol-4-carboxylic acid [5-(3-dimethylaminomethylphenyl)-1-(toluene-4-sulfonyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]amide 
• 1449319-82-7 1-benzyl-1H-pyrazol-4-carboxylic acid [5-(3-dimethylaminomethylphenyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]amide 
• 1449319-96-3 1-benzyl-1H-pyrazol-4-carboxylic acid {5-[3-(3,3-difluoropiperidin-1-ylmethyl)phenyl]-1H-pyrrolo[2,3-b]pyridin-3-yl}amide 
• 1449319-98-5 1-benzyl-1H-pyrazol-4-carboxylic acid [5-[3-(3,3-difluoropiperidin-1-ylmethyl)phenyl]-1-(toluene-4-sulfonyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]amide 
• 1449320-04-0 1-benzyl-1H-pyrazol-4-carboxylic acid [5-(5-pyrrolidin-1-ylmethylthiophen-2-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]amide 
• 1449320-08-4 1-benzyl-1H-pyrazol-4-carboxylic acid [5-(5-pyrrolidin-1-ylmethylthiophen-3-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]amide 
• 1449320-11-9 1-benzyl-1H-pyrazol-4-carboxylic acid {5-[5-(3,3-difluoroazetidin-1-ylmethyl)thiophen-3-yl]-1H-pyrrolo[2,3-b]pyridin-3-yl}amide 

Relevant articles and documents

Tianqitinib, as well as preparation method and application thereof

The invention provides tianqitinib, as well as a preparation method and application thereof, and provides an amide substituted azaindole compound or pharmaceutically acceptable salt thereof, or solvate or prodrug thereof. The compound has a structure as shown in a formula I. The compound can be used for remarkably inhibiting the enzyme activity of TRK at the molecular level, and has remarkable inhibiting effect on phosphorylation/activation of TRK at the cell level. Furthermore, the compound can be used for remarkably inhibiting growth of nude mice xenograft of human tumor cell lines, and hasa wide market application prospect.

PROTEIN KINASE INHIBITORS FOR PROMOTING LIVER REGENERATION OR REDUCING OR PREVENTING HEPATOCYTE DEATH

The invention relates to MKK4 (mitogen-activated protein kinase 4) and their use in promoting liver regeneration or reducing or preventing hepatocyte death. The MKK4 inhibitors selectively inhibit protein kinase MKK4 over protein kinases JNK and MKK7.

1H-PYRROLO[2,3-B] PYRIDINE DERIVATIVES AND THEIR USE AS KINASE INHIBITORS

The inventions relates to compounds of (I) and therapeutic uses thereof : (I) The terms Z, Y, and R1 are as defined in the claims.